Lucentix
Lausanne, Vaud, Switzerland
About Lucentix
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme called luciferase, is engineered to change the color of the emitted light in response to changes in analyte concentration. In absence of the analyte the molecular system emits red light, while at high analyte concentration the light is blue. Lucentix is headquartered in Lausanne, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $137.5K
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2015)
- Website: lucentix.ch
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Sensor
Canonical: https://fsome.com/organization/lucentix-2585395 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.